Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

EyeTech completes enrollment in two pivotal Macugen trials

Aug. 12, 2002

Collagen-derived agent for dry eye syndrome licensed by Santen

July 25, 2002

Selective adenosine A3 receptor ligand reduces IOP in monkeys

July 18, 2002

Retinal neuroprotective effects demonstrated for (-)-MR-22 and flunarizine in rat model

July 17, 2002

Another major launch for Alcon's prostaglandin analogue for glaucoma

July 15, 2002

Inspire presents melatonin analogues with IOP-reducing properties

July 10, 2002

Mast cell stabilizers synthesized at Alcon active in model of allergic conjunctivitis

June 20, 2002

Phase III results announced for INS-365 Ophthalmic in dry eye

June 19, 2002

Periostat enters clinical study for meibomianitis

June 19, 2002

Miravant and Bausch & Lomb to review SnET2 data with license option

June 13, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...